Shirr Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 08-12-2024
- Paid Up Capital ₹ 0.10 M
as on 08-12-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.48 M
as on 08-12-2024
- Revenue -8.01%
(FY 2017)
- Profit 8.11%
(FY 2017)
- Ebitda -34.32%
(FY 2017)
- Net Worth 5.35%
(FY 2017)
- Total Assets 0.84%
(FY 2017)
About Shirr Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.48 M.
Jayakrishnan Nair and Asharani Sadasivan serve as directors at the Company.
- CIN/LLPIN
U51397KL2007PTC020592
- Company No.
020592
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media
Who are the key members and board of directors at Shirr Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayakrishnan Nair  | Managing Director | 30-Mar-2007 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Asharani Sadasivan | Director | 27-Jul-2009 | Current |
Financial Performance of Shirr Pharmaceuticals.
Shirr Pharmaceuticals Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 8.01% decrease. The company also saw a slight improvement in profitability, with a 8.11% increase in profit. The company's net worth moved up by a moderate rise of 5.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shirr Pharmaceuticals?
In 2017, Shirr Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Mar 2023 | ₹1.48 M | Open |
How Many Employees Work at Shirr Pharmaceuticals?
Shirr Pharmaceuticals has a workforce of 8 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shirr Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shirr Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
